Pharvaris Statistics

Total Valuation

Pharvaris has a market cap or net worth of $988.07 million. The enterprise value is $587.06 million.

Market Cap	988.07M
Enterprise Value	587.06M

Important Dates

The next estimated earnings date is Monday, August 5, 2024, before market open.

Earnings Date	Aug 5, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharvaris has 53.82 million shares outstanding. The number of shares has increased by 21.30% in one year.

Shares Outstanding	53.82M
Shares Change (YoY)	+21.30%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.53%
Owned by Institutions (%)	85.88%
Float	18.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.53
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-123.96

Financial Efficiency

Return on equity (ROE) is -39.70% and return on invested capital (ROIC) is -28.98%.

Return on Equity (ROE)	-39.70%
Return on Assets (ROA)	-37.40%
Return on Capital (ROIC)	-28.98%
Revenue Per Employee	n/a
Profits Per Employee	-$1.41M
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Pharvaris has paid $1.39 million in taxes.

Income Tax	1.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.42% in the last 52 weeks. The beta is -3.10, so Pharvaris's price volatility has been lower than the market average.

Beta (5Y)	-3.10
52-Week Price Change	+16.42%
50-Day Moving Average	18.70
200-Day Moving Average	22.04
Relative Strength Index (RSI)	50.74
Average Volume (20 Days)	53,448

Short Selling Information

The latest short interest is 137,524, so 0.26% of the outstanding shares have been sold short.

Short Interest	137,524
Short Previous Month	119,546
Short % of Shares Out	0.26%
Short % of Float	0.73%
Short Ratio (days to cover)	1.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-113.45M
Pretax Income	-114.36M
Net Income	-115.50M
EBITDA	-113.16M
EBIT	-113.45M
Earnings Per Share (EPS)	-$2.71

Full Income Statement

Balance Sheet

The company has $401.22 million in cash and $207,462 in debt, giving a net cash position of $401.01 million or $7.45 per share.

Cash & Cash Equivalents	401.22M
Total Debt	207,462
Net Cash	401.01M
Net Cash Per Share	$7.45
Equity (Book Value)	391.23M
Book Value Per Share	7.27
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$100.29 million and capital expenditures -$110,728, giving a free cash flow of -$100.41 million.

Operating Cash Flow	-100.29M
Capital Expenditures	-110,728
Free Cash Flow	-100.41M
FCF Per Share	-$2.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pharvaris does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.30%
Shareholder Yield	-21.30%
Earnings Yield	-11.69%
FCF Yield	-10.16%

Analyst Forecast

The average price target for Pharvaris is $32.80, which is 78.65% higher than the current price. The consensus rating is "Buy".

Price Target	$32.80
Price Target Difference	78.65%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2